Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025
17 déc. 2024 15h00 HE
|
Nordicus Partners Corporation
BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...